<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LEVORPHANOL TARTRATE</span><br/>(lee-vor'fa-nole)<br/><span class="topboxtradename">Levo-Dromoran<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic</span>; <span class="classification">narcotic (opiate) agonist</span><br/><b>Prototype: </b>Morphine Sulfate<br/><b>Pregnancy Category: </b>B<br/><b>Controlled Substance: </b>Schedule II<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2 mg tablets; 2 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>A potent synthetic morphine derivative with agonist activity only. Reported to cause less nausea, vomiting, and constipation
         than equivalent doses of morphine but may produce more sedation, smooth-muscle stimulation, and respiratory depression.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>More potent as an analgesic and has somewhat longer duration of action than morphine.</p>
<h1><a name="uses">Uses</a></h1>
<p>To relieve moderate to severe pain. Also preoperatively to allay apprehension.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to levorphanol; labor and delivery, lactation. Safety and effectiveness in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with impaired respiratory reserve, or depressed respirations from another cause (e.g., severe infection, obstructive
         respiratory conditions, chronic bronchial asthma). Patients with head injury or increased intracranial pressure; acute MI,
         cardiac dysfunction; liver disease, biliary surgery, alcohol or delirium tremens; liver or kidney dysfunction, hypothyroidism,
         Addison's Disease, toxic psychosis, prostatic hypertrophy, or urethral stricture. Concurrent use with CNS depressant drugs;
         pregnancy (category C); older adults, other vulnerable populations.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Moderate to Severe Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 23 mg q68h prn <span class="rdroute">SC/IM</span> 12 mg q68h prn <span class="rdroute">IV</span> Up to 1 mg q36h prn<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral/</span><span class="adminroutetype">Subcutaneous/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give in the smallest effective dose to minimize the possibility of tolerance and physical dependence.</li>
<li>Rotate injection sites.</li>
<li>Store tablets and injection at 15°30° C (59°86° F) unless otherwise directed. Store tablets
            in tightly covered, light-resistant containers.
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Dilute in 35 mL sterile water or NS.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give slowly over 45 min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>Aminophylline,</b>
<b>ammonium chloride,</b>
<span class="classification">barbiturates</span>, <b>chlorothiazide,</b>
<b>heparin,</b>
<b>methicillin,</b>
<b>phenytoin,</b>
<b>sodium bicarbonate.</b>
</p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Euphoria, <span class="speceff-common">sedation, drowsiness,</span> nervousness, confusion. <span class="typehead">CV:</span> Hypotension, fast, slow, or pounding heartbeat. <span class="typehead"> GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, dry mouth, cramps, <span class="speceff-common">constipation</span>. <span class="typehead">Urogenital:</span> Urinary frequency, urinary retention, sedation. <span class="typehead">Special Senses:</span> Blurred vision. <span class="typehead">Respiratory:</span> Respiratory depression. <span class="typehead">Body as a Whole:</span> Physical dependence. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> and other <span class="classification">cns depressants</span> compound sedation and CNS depression. <span class="typehead">Herbal:</span>
<b>St. John's wort</b> may increase sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Peak:</span> 6090 min. <span class="typehead">Duration:</span> 68 h. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 1.2 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess degree of pain relief. Drug is most effective when peaks and valleys of pain relief are avoided.</li>
<li>Monitor bowel function.</li>
<li>Monitor ambulation, especially in older adult patients.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in other potentially hazardous activities.</li>
<li>Avoid alcohol and other CNS depressants unless approved by physician.</li>
<li>
            							Note: Ambulation may increase frequency of nausea and vomiting.
            						
         </li>
<li>Increase fluid and fiber intake to offset constipating effects of the drug.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>